These findings suggest a potentially important, but probably opposite role for SPDL1 protein and mRNA in the clinical behavior of pancreatic adenocarcinoma, but this conclusion is limited by the fact that our protein and mRNA results came from two different study population, i.e., own cohort and TCGA cohort, respectively. This evidence concerns the gene SPDL1 and pancreatic adenocarcinoma.